Sodium Valproate (VPA) CAS 1069-66-5 API Factory High Purity

Short Description:

Chemical Name: Sodium Valproate (VPA)

Synonyms: Valproic Acid Sodium Salt

CAS: 1069-66-5

Appearance: White or Almost White Crystalline Powder, Hygroscopic

Assay: 98.5%~101.0% (Titration)

A Broad-Spectrum Anti-Epileptic Drug Usually Well Tolerated

API High Quality, Commercial Production

Inquiry: alvin@ruifuchem.com

Send email to us

Product Detail

Product Tags

Description:

Manufacturer Commercial Supply with High Purity and Stable Quality
Chemical Name: Sodium Valproate (VPA)
CAS: 1069-66-5

Chemical Properties:

Chemical Name	Sodium Valproate
Synonyms	VPA; Valproic Acid Sodium Salt; Sodium 2-Propylpentanoate
CAS Number	1069-66-5
CAT Number	RF-API14
Stock Status	In Stock, Production Scale Up to Tons
Molecular Formula	C8H15NaO2
Molecular Weight	166.20
Melting Point	300℃
Density	1.0803 g/cm3
Water Solubility	Soluble in Water
Shipping Condition	Under Ambient Temperature
Brand	Ruifu Chemical

Specifications:

Item	Specifications
Appearance	White or Almost White Crystalline Powder, Hygroscopic
Identification	Infrared Spectrum By RT comparison Reactions of Sodium Salt
Solubility	Very Soluble in Water, Freely Soluble in Ethanol
Acidity or Alkalinity	According to EP Criterions
Clarity & Color of Solution	According to EP Criterions
Heavy Metals	≤20ppm
Sulfates	≤200ppm
Chloride	≤200ppm
Loss on Drying	≤2.0%
Any Impurity	≤0.10% (GC)
Total Impurities	≤0.30% (GC)
Assay	98.5%~101.0% (Titration)
Test Standard	European Pharmacopeia (EP)
Usage	Active Pharmaceutical Ingredient (API)

Package & Storage:

Package: Bottle, Aluminum foil bag, Cardboard drum, 25kg/Drum, or according to customer's requirement.

Storage Condition: Store in sealed containers at cool and dry place; Protect from light, moisture and pest infestation.

Advantages:

FAQ:

Application:

Sodium Valproate (CAS: 1069-66-5) is an anticonvulsant and effective agent for control of both absence and primarily generalized tonic-clonic seizures. Valproic acid sodium salt (Sodium Valproate) is a histone deacetylase (HDAC) inhibitor, with IC50 in the range of 0.5 and 2 mM, also inhibits HDAC1 (IC50, 400 μM), and induces proteasomal degradation of HDAC2. Valproic acid sodium salt activates Notch1 signaling and inhibits proliferation in small cell lung cancer (SCLC) cells. Sodium Valproate (CAS: 1069-66-5) is used in the treatment of epilepsy, bipolar disorder and prevention of migraine headaches.